GlobeVerge logoGlobeVerge
Home / business
WORLD

We're increasing our Eli Lilly price target after another beat-and-raise quarter

CNBC · Published 2h ago
We're increasing our Eli Lilly price target after another beat-and-raise quarter

The strength of its GLP-1 business suggests the stock still has more room to run.

GlobeSignal
Market Mover

Developments like this can have effects beyond the immediate story.

Expand
Overall ImportanceHigh
Confidence★☆☆☆☆
Most Affected
  • Governments
  • Businesses
  • General public
Likely Next
  • Official response
  • Follow-up coverage
  • Public reaction
Ripple EffectEventResponsePolicyPublic
Why It Matters

Developments like this can have effects beyond the immediate story.

Read the full story at CNBC →
Share: X / Twitter WhatsApp Facebook Email

More in General

GlobeSignal: A transparent, keyword-based read on this story's tone and stakes—not financial, political or safety advice. The summary above is the original publisher's excerpt, not AI-generated or rewritten by GlobeVerge. Open the original source link before acting on any story.